NVAX stock price inched down to $4.55 amid profit-taking by day traders. Options market activity shows increased put volume, hinting at hedging strategies among large market players. Here you will find sketches , musical performances, promos, and behind-the-scenes content featuring all your favorite cast members, hosts, and musical guests. Welcome to the official Saturday... In the case of Novavax, the consensus sales estimate of $130.5 million for the current quarter points to a year-over-year change of -68.6%. The $942.33 million and $516.45 million estimates for the current and next fiscal years indicate changes of +38.1% and -45.2%, respectively. NVAX stock price sits at $4.66 amid heightened chatter about mergers in the biotech sector. A wave of consolidation could re-rate valuations, benefiting companies with unique IP portfolios like NVAX.